The only problem is that Cramer doesn't know what he's talking about. I wear both an Omnipod and a Dexcom. Both technologies are great innovations but not perfect. It is my understanding that Animas (Owned by J&J) will be releasing an upgrade to their Ping pump that will integrate the Dexcom.
My understanding is that it will alarm and have an automatic cutoff if the glucose levels fall below a specified level, however it will not increase the delivery of insulin when the level rises. this is because it is more dangerous in the short term to have very low sugar than a high for a short time.
Speculation Friday, the stock sure jumped up after his comments. I can't believe Cramer would recommend 2 companies that have combined revenue of $200 million and a market cap of $2 billion. Is that out of wack? I don't think he took time to mentioned PODD has sold stock every year and even if they grow by 30% the analyst don't think they will make any money for awhile. It is an exciting technology, it works. Looks like this stock is headed higher despite the basics.